- Home
- IBRX vs OSW Comparison
IBRX vs OSW Comparison
Compare IBRX & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- OSW
- Stock Information
- Founded
- IBRX 2014
- OSW 2017
- Country
- IBRX United States
- OSW Bahamas
- Employees
- IBRX N/A
- OSW N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- OSW Hotels/Resorts
- Sector
- IBRX Health Care
- OSW Consumer Discretionary
- Exchange
- IBRX Nasdaq
- OSW Nasdaq
- Market Cap
- IBRX 2.3B
- OSW 2.3B
- IPO Year
- IBRX N/A
- OSW N/A
- Fundamental
- Price
- IBRX $2.31
- OSW $22.71
- Analyst Decision
- IBRX Strong Buy
- OSW Strong Buy
- Analyst Count
- IBRX 5
- OSW 3
- Target Price
- IBRX $10.20
- OSW $22.67
- AVG Volume (30 Days)
- IBRX 9.0M
- OSW 471.9K
- Earning Date
- IBRX 08-05-2025
- OSW 07-30-2025
- Dividend Yield
- IBRX N/A
- OSW 0.71%
- EPS Growth
- IBRX N/A
- OSW 32.03
- EPS
- IBRX N/A
- OSW 0.68
- Revenue
- IBRX $56,600,000.00
- OSW $919,258,000.00
- Revenue This Year
- IBRX $629.94
- OSW $8.52
- Revenue Next Year
- IBRX $109.91
- OSW $8.82
- P/E Ratio
- IBRX N/A
- OSW $33.31
- Revenue Growth
- IBRX 4227.22
- OSW 8.51
- 52 Week Low
- IBRX $1.83
- OSW $14.21
- 52 Week High
- IBRX $7.48
- OSW $23.28
- Technical
- Relative Strength Index (RSI)
- IBRX 45.80
- OSW 58.16
- Support Level
- IBRX $2.17
- OSW $22.10
- Resistance Level
- IBRX $2.43
- OSW $23.28
- Average True Range (ATR)
- IBRX 0.15
- OSW 0.57
- MACD
- IBRX 0.00
- OSW 0.06
- Stochastic Oscillator
- IBRX 27.92
- OSW 74.44
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.